No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial
- 29 October 2015
- journal article
- research article
- Published by Taylor & Francis in Blood Pressure
- Vol. 25 (2) , 83-92
Abstract
No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial. . ???aop.label???. doi: 10.3109/08037051.2015.1106750Keywords
This publication has 17 references indexed in Scilit:
- The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHgBlood Pressure, 2015
- Treatment of Hypertension in Patients With Coronary Artery DiseaseCirculation, 2015
- Antihypertensive Therapy and the J-curve: Fact or Fiction?Current Hypertension Reports, 2015
- Effects of blood pressure lowering on outcome incidence in hypertensionJournal Of Hypertension, 2014
- The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)Clinical Trials, 2014
- 2013 ESH/ESC Practice Guidelines for the Management of Arterial HypertensionBlood Pressure, 2013
- J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) TrialEuropean Heart Journal, 2010
- Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?Annals of Internal Medicine, 2006
- Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialThe Lancet, 2004
- Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE TrialBlood Pressure, 2001